Prevalence and risk factors of adverse effects after the first COVID-19 booster dose: evidence from Greece

Petros Galanis, Aglaia Katsiroumpa, Irene Vraka, Vanessa Chrysagi, Olga Siskou, Olympia Konstantakopoulou, Theodoros Katsoulas, Parisis Gallos, Daphne Kaitelidou
doi: https://doi.org/10.1101/2023.03.27.23287816

Article usage

Article usage: March 2023 to January 2025

AbstractFullPdf
Mar 2023461660
Apr 2023180245
May 20233317
Jun 20231654
Jul 202315110
Aug 202321106
Sep 20232345
Oct 20231433
Nov 202322122
Dec 20231101
Jan 2024601
Feb 20241411
Mar 20241326
Apr 20241234
May 20241122
Jun 20241325
Jul 20246211
Aug 2024602
Sep 20242289
Oct 2024846
Nov 20241307
Dec 2024717
Jan 2025800
Back to top
Posted March 28, 2023.
Download PDF
Data/Code
Email
Prevalence and risk factors of adverse effects after the first COVID-19 booster dose: evidence from Greece
Petros Galanis, Aglaia Katsiroumpa, Irene Vraka, Vanessa Chrysagi, Olga Siskou, Olympia Konstantakopoulou, Theodoros Katsoulas, Parisis Gallos, Daphne Kaitelidou
medRxiv 2023.03.27.23287816; doi: https://doi.org/10.1101/2023.03.27.23287816
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area